Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jacksonville, FL
NPI
1447252523
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
915 W Monroe St Ste 200
Jacksonville, FL, 32204
Phone (904) 384-2240
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
2,592 services
Medicare patients, 2024
613
Average age 75
Drug cost, 2024
$5.4M
6,965 prescriptions
Company payments, 2025
$63K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David R Sutton Jr. was code 99214 (office e&m - established), 1,260 times for 573 patients. In total David R Sutton Jr. billed 2,592 services in 20 codes, and Medicare paid $153K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,260 | 573 | $88.49 | $112K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 569 | 308 | $11.50 | $6,545 |
| 95251 Test - Miscellaneous | Office | 425 | 169 | $25.82 | $11K |
| 76536 Ultrasound - Nonspecific | Office | 202 | 170 | $75.06 | $15K |
| 99213 Office E&M - Established | Office | 37 | 32 | $63.30 | $2,342 |
| 93882 Duplex Scan - Extracranial Arteries | Office | 22 | 17 | $81.23 | $1,787 |
| 77080 Standard X-ray | Office | 19 | 19 | $37.00 | $703 |
| 10005 Other Organ Systems | Office | 16 | 14 | $97.14 | $1,554 |
By year: 2022 $158K for 2,940 services; 2023 $162K for 2,127 services; 2024 $153K for 2,592 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 185 | 168 | $2.99 | $553 |
| 80053 Clinical Chemistry | 167 | 153 | $10.53 | $1,758 |
| 83036 Blood Count | 159 | 146 | $9.68 | $1,539 |
| 80061 Clinical Chemistry | 152 | 141 | $13.35 | $2,030 |
| 84443 Clinical Chemistry | 87 | 82 | $16.76 | $1,458 |
| 82570 Clinical Chemistry | 71 | 70 | $5.16 | $367 |
| 82044 Clinical Chemistry | 71 | 70 | $6.21 | $441 |
| 84439 Clinical Chemistry | 57 | 55 | $9.00 | $513 |
| 82306 Clinical Chemistry | 17 | 17 | $29.48 | $501 |
| 84403 Clinical Chemistry | 17 | 16 | $25.75 | $438 |
Medicare prescription drug claims, 2024
In 2024, the drug David R Sutton Jr. prescribed most often to Medicare patients was Levothyroxine Sodium, with 542 prescriptions and refills. In total David R Sutton Jr. wrote 6,965 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 542 | 1,476 | 148 | $5,996 |
| Jardiance Empagliflozin | 419 | 837 | 105 | $481K |
| Mounjaro Tirzepatide | 412 | 540 | 78 | $564K |
| Ozempic Semaglutide | 406 | 622 | 91 | $583K |
| Metformin Hcl Er Metformin Hcl | 349 | 1,035 | 110 | $3,838 |
| Synthroid Levothyroxine Sodium | 335 | 886 | 95 | $37K |
| Pioglitazone Hcl Generic | 287 | 798 | 91 | $3,629 |
| Rosuvastatin Calcium Generic | 256 | 735 | 89 | $3,749 |
| Tresiba Flextouch U-200 Insulin Degludec | 227 | 494 | 66 | $208K |
| Metformin Hcl Generic | 164 | 444 | 52 | $1,199 |
| Atorvastatin Calcium Generic | 149 | 443 | 47 | $2,400 |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 119 | 181 | 31 | $191K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 96 | 184 | 30 | $125K |
| V-Go 20 Sub-Q Insulin Device, 20 Unit | 95 | 123 | 18 | $61K |
| Losartan Potassium Generic | 95 | 284 | 31 | $888 |
Brand drugs: 3,630 claims; generic drugs: 2,808 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David R Sutton Jr. $63K ($63K in general payments such as food, travel and fees) from 31 companies. The largest payer was Lilly USA, LLC with $40K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 52 | $40K |
| Novo Nordisk Inc NVO | 34 | $14K |
| Abbvie Inc. ABBV | 3 | $3,164 |
| Abbott Laboratories ABT | 35 | $2,726 |
| Insulet Corporation PODD | 48 | $539 |
| Corcept Therapeutics CORT | 14 | $507 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $346 |
| Ascendis Pharma Endocrinology Inc ASND | 8 | $245 |
| CeQur Corporation | 1 | $235 |
| Dexcom, Inc. DXCM | 10 | $217 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.